Breaking News on Pharmaceutical Technology

Headlines > Processing & QC

News in brief

BAC BV and Life Teschnologies team up on processing columns

07-Feb-2012 - BAC BV and Life Technologies have launched a new range of affinity columns will ‘unlock’ high speed affinity HPLC for pharmaceutical processing.

US consent decree act aims to stop “regulatory frenzy”

07-Feb-2012 - A proposed US act aims to impose limitations on consent decrees and stop the “regulatory frenzy in Washington”.

UPDATE

Tamil Nadu will be next manufacturing hit if makers meet WHO standards, says IDMA

06-Feb-2012 - The Indian Drug Manufacturers Association (IDMA) plans to amp up pharma business in Tamil Nadu by helping more companies meet WHO production standards.

Annual WHO meeting to tackle spread of substandard drugs

06-Feb-2012 - The WHO is urging countries to collaborate on tackling substandard drugs and strengthening supply chains at a new annual meeting.

FDA calls for more powers to adopt nationwide ePedigree

02-Feb-2012 - The US FDA has called for more authority to ensure any track-and-trace system is binding for industry and pre-empts state laws.

Novartis hit with another 483 after FDA finds repeat failings

31-Jan-2012 - The FDA has hit Novartis with another 483 after finding seven repeat observations and a backlog of 1,360 overdue consumer complaints.

FDA updates Q&A to cut topical antiseptic contamination

30-Jan-2012 - The FDA has updated its question and answer document to help manufacturers of topical antiseptics prevent contamination.

Manufacturing issues round-up

26-Jan-2012 - in-PharmaTechnologist presents a round-up of issues within the pharmaceutical manufacturing industry, including Novartis’ plans to restart Nebraska ops and problems for Roche at it’s South Carolina facility.

US hits Ranbaxy with injunction to boost manufacturing quality

26-Jan-2012 - The US has filed a “groundbreaking” injunction against Ranbaxy to force the generic giant to make “fundamental changes” at its plants.

News in brief

Vivalis grows sales as demand for vaccine cell line increases

25-Jan-2012 - Vivalis nearly doubled revenues from its vaccine production platform in 2011 and has inked a third mAb discovery programme with Sanofi.

FDA & EMA plant approvals to cut bottlenecks at Genzyme

24-Jan-2012 - The FDA has followed the EMA in approving the Framingham, MA plant that Genzyme hopes will cut production bottlenecks.

SSB teams with Refine Technology to improve connectivity in biomanufacturing

24-Jan-2012 - Sartorius Stedim Biotech (SSB) says its partnership with Refine Technology will help meet demand for greater connectivity between retention devices and bioreactors and save Pharmas time and money

Pharmacy aseptic failings likely cause of vision loss; researchers

23-Jan-2012 - Poor aseptic technique at compounding pharmacies is the most likely cause of Avastin-related vision loss, researchers claim.

SGS to open 2nd Indian lab on schedule; 2011 revs grow despite ‘tough’ European market

19-Jan-2012 - SGS’ new analytical lab in Mumbai, India will open later this week just six months after the analytical services firm began its construction .

SSB teams with G-Con on modular bioproduction techs

19-Jan-2012 - Sartorius Stedum Biotech (SSB) and G-Con Manufacturing claim their biomanufacturing technology partnership will change the ‘fundamentals’ of process design.

FDA publishes QbD example to help generics firms file ANDAs

19-Jan-2012 - The FDA has published a QbD approach to modified release tablet development to help generic companies meet its 2013 deadline.

PIC/S adds GDP to remit to tackle supply chain threats

17-Jan-2012 - PIC/S has strengthened promotion of global GDP harmonisation and confidentiality in a revision to its documentation.

FDA plans to boost oversight using foreign regulators’ info

17-Jan-2012 - The US FDA plans to study foreign regulators’ GMP inspection reports with a view to using them to support its enforcement efforts.

FDA plans overseas inspections as GDUFA goes to Congress

16-Jan-2012 - The US FDA has sent its generic user fee recommendations to Congress ahead of a meeting to discuss the plan next month.

China wants vaccine production innovation to boost local sector

16-Jan-2012 - The Chinese government is encouraging development of new vaccine production processes in a bid to achieve self-reliance.

Collaboration needed to reverse supply chain “neglect”; expert

11-Jan-2012 - Greater collaboration between regulators, suppliers and manufacturers is needed to reverse decades of supply chain neglect, an expert said.

Bumpy road ahead for Hospira but issues “fixable”, CEO says

11-Jan-2012 - Hospira will uncover more issues as it gets to the root cause of its quality troubles but the situation is “very fixable”, its CEO said.

US fake drug seizures up 200%

10-Jan-2012 - The value of counterfeit pharmaceuticals seized at US borders jumped 200 per cent in 2011 as enforcement actions took effect.

Novartis to take $120m charge to fix US plant, recall OTC drugs

09-Jan-2012 - Novartis expects to take a $120m charge to improve a US manufacturing plant and recall drugs after the FDA sent it a 483.

USP publishes draft supply chain integrity chapter

09-Jan-2012 - The USP has published draft supply chain integrity guidance outlining steps to stop counterfeit or adulterated drugs reaching patients.

Sign up for your free newsletter

Supplier Webinars